BioLine RX Ltd (BLRX) — Financial Flexibility Index
BioLine RX Ltd (BLRX) has a Financial Flexibility Index of -0.10x as of September 2025. Free cash flow of ILA-2.11 Million (operating CF ILA-2.11 Million minus capex ILA0.00) represents 0% of total liabilities (ILA20.27 Million). Also explore BLRX shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioLine RX Ltd Financial Flexibility Index (2010–2024)
Historical Financial Flexibility Index trend for BioLine RX Ltd across 15 annual periods. Check BLRX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BioLine RX Ltd (2010–2024)
Year-by-year free cash flow to debt coverage for BioLine RX Ltd. For the full company profile including market capitalisation, see BioLine RX Ltd (BLRX) total market value.
| Year | Flexibility Index | Free Cash Flow (ILA) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.72x | ILA-43.82 Million | ILA-43.87 Million | ILA25.45 Million | ▼ -291.4% |
| 2023 | -0.44x | ILA-22.31 Million | ILA-22.61 Million | ILA50.70 Million | ▲ +56.6% |
| 2022 | -1.01x | ILA-25.92 Million | ILA-26.24 Million | ILA25.54 Million | ▲ +42.5% |
| 2021 | -1.76x | ILA-23.48 Million | ILA-23.57 Million | ILA13.30 Million | ▼ -92.9% |
| 2020 | -0.91x | ILA-23.11 Million | ILA-23.21 Million | ILA25.26 Million | ▲ +18.3% |
| 2019 | -1.12x | ILA-22.59 Million | ILA-22.67 Million | ILA20.19 Million | ▼ -19.4% |
| 2018 | -0.94x | ILA-13.98 Million | ILA-24.19 Million | ILA14.91 Million | ▲ +53.5% |
| 2017 | -2.02x | ILA-16.31 Million | ILA-20.55 Million | ILA8.08 Million | ▲ +45.4% |
| 2016 | -3.70x | ILA-14.46 Million | ILA-14.51 Million | ILA3.91 Million | ▼ -19.2% |
| 2015 | -3.10x | ILA-11.45 Million | ILA-14.17 Million | ILA3.69 Million | ▲ +4.6% |
| 2014 | -3.25x | ILA-14.30 Million | ILA-14.48 Million | ILA4.40 Million | ▼ -33.5% |
| 2013 | -2.43x | ILA-20.12 Million | ILA-20.23 Million | ILA8.27 Million | ▼ -14.0% |
| 2012 | -2.14x | ILA-19.94 Million | ILA-20.11 Million | ILA9.34 Million | ▼ -32.9% |
| 2011 | -1.61x | ILA-10.94 Million | ILA-11.22 Million | ILA6.81 Million | ▼ -400.3% |
| 2010 | 0.54x | ILA12.12 Million | ILA11.46 Million | ILA22.65 Million | — |